This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Mid-Caps With Upside: Analysts

5. Nektar Therapeutics (NKTR - Get Report) is a clinical-stage biopharmaceutical major.

The company reported a loss of 24 cents per share for 2010 fourth quarter against a loss of 8 cents and 9 cents per share in the year-ago and quarter-ago periods, respectively. Loss per share is pegged at $1.31 for 2011 and $1.16 cents for 2012.

The stock has a 73% upside over the next 12 months with a consensus target price of $15.4, analysts polled by Bloomberg forecast. In comparison, pharma giants Johnson & Johnson (JNJ), Pfizer (PFE), Merck (MRK), Abbott Laboratories (ABT), Bristol Myers Squibb (BMY) and Eli Lilly (LLY) have upsides of 1%-16%.

Of the 11 analysts covering the stock, 8 recommend buying and 3 suggest holding, representing 73% buy ratings.

6 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
CLWR $0.00 0.00%
LCC $0.00 0.00%
DNDN $0.06 -6.02%
NKTR $11.41 2.15%
TIVO $10.71 -0.88%

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs